Literature DB >> 12933931

Serum IgG antibodies to P0 dimer and 35 kDa P0 related protein in neuropathy associated with monoclonal gammopathy.

A Favereaux1, A Lagueny, A Vital, J-M Schmitter, S Chaignepain, X Ferrer, I Labatut-Cazabat, C Vital, K G Petry.   

Abstract

BACKGROUND: Peripheral neuropathies (PN) associated with monoclonal gammopathy (MG) are widely considered as autoimmune disorders, but the putative role of incriminated antigens is still not understood.
OBJECTIVE: Fifty five patients with PN associated with MG were studied to investigate whether new antigens could be found, and to evaluate their relation to clinical manifestations.
METHODS: An immunological study was conducted on patient sera to identify autoreactivities against nerve proteins by western blotting. Antigen proteins were purified and analysed by proteomic tools. Correlation with ultrastrucural and clinical features was then studied.
RESULTS: Of the 55 patients suffering from PN associated with MG, 17 exhibited IgG autoantibodies directed against peripheral nerve proteins of 35, 58, and 60 kDa. N-terminal microsequencing and mass spectrometry analyses of the 35 kDa protein revealed perfect peptidic matching with 47% of the amino acid sequence of P0, whereas the 58 and 60 kDa proteins were identified as the reduced and non-reduced forms of a P0 dimer. Deglycosylation did not affect IgG binding to the 35 kDa P0 related protein, suggesting a peptidic epitope. In contrast, deglycosylation abolished IgG recognition of the P0 dimer protein, so that a carbohydrate moiety may be implicated in the epitope formation. This confirmed the existence of two different types of IgG, one recognising the 58 and 60 kDa proteins and one directed against the 35 kDa protein.
CONCLUSIONS: This is the first report of antibody activity directed against the dimeric association of P0. Although P0 oligomerisation and adhesion properties play a crucial part in the myelin sheath compaction, the pathogenic significance of these autoantibodies needs further investigations to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933931      PMCID: PMC1738647          DOI: 10.1136/jnnp.74.9.1262

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  27 in total

1.  A protein with the characters of a zinc-finger is implicated in the differentiation of Schwann cells.

Authors:  I Labatut-Cazabat; A Vekris; K G Petry
Journal:  Neuroreport       Date:  1999-09-29       Impact factor: 1.837

2.  Three different anti-myelin antibodies in a case of demyelinating dysglobulinemic peripheral neuropathy.

Authors:  E Ellie; A B Younes-Chennoufi; A Couto; A Vital; S Hilmi; J Demotes-Mainard; N Baumann; K G Petry
Journal:  J Peripher Nerv Syst       Date:  1997       Impact factor: 3.494

Review 3.  Anti-ganglioside antibody and neuropathy: review of our research.

Authors:  N Yuki
Journal:  J Peripher Nerv Syst       Date:  1998       Impact factor: 3.494

4.  Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin.

Authors:  G Lemke; R Axel
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

5.  Reactivity with neural cell adhesion molecules in sera from patients with demyelinating diseases.

Authors:  M Poltorak; A J Steck; M Schachner
Journal:  Neurosci Lett       Date:  1986-04-11       Impact factor: 3.046

6.  The J1 glycoprotein--a novel nervous system cell adhesion molecule of the L2/HNK-1 family.

Authors:  J Kruse; G Keilhauer; A Faissner; R Timpl; M Schachner
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

7.  P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  W X Yan; J J Archelos; H P Hartung; J D Pollard
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

8.  Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1.

Authors:  J Kruse; R Mailhammer; H Wernecke; A Faissner; I Sommer; C Goridis; M Schachner
Journal:  Nature       Date:  1984 Sep 13-19       Impact factor: 49.962

9.  A possible novel isoform of peripheral myelin P0 protein: a target antigen recognized by an autoantibody in a patient with malignant lymphoma and peripheral neuropathy.

Authors:  K Ishida; H Takeuchi; R Takahashi; K Yoshimura; M Yamada; H Mizusawa
Journal:  J Neurol Sci       Date:  2001-07-15       Impact factor: 3.181

10.  Two forms of 1B236/myelin-associated glycoprotein, a cell adhesion molecule for postnatal neural development, are produced by alternative splicing.

Authors:  C Lai; M A Brow; K A Nave; A B Noronha; R H Quarles; F E Bloom; R J Milner; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

View more
  4 in total

1.  L-MPZ, a novel isoform of myelin P0, is produced by stop codon readthrough.

Authors:  Yoshihide Yamaguchi; Akiko Hayashi; Celia W Campagnoni; Akio Kimura; Takashi Inuzuka; Hiroko Baba
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

2.  Myelin protein zero is naturally processed in the B cells of monoclonal gammopathy of undetermined significance of immunoglobulin M isotype: aberrant triggering of a patient's T cells.

Authors:  Eva Hellqvist; Maria Kvarnström; Anita Söderberg; Magnus Vrethem; Jan Ernerudh; Anders Rosén
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

3.  How Does Protein Zero Assemble Compact Myelin?

Authors:  Arne Raasakka; Petri Kursula
Journal:  Cells       Date:  2020-08-04       Impact factor: 6.600

Review 4.  Flexible Players within the Sheaths: The Intrinsically Disordered Proteins of Myelin in Health and Disease.

Authors:  Arne Raasakka; Petri Kursula
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.